These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2725937)

  • 1. [The Denver peritoneojugular shunt. Current indications].
    Bracci F; Bracaglia C; Zampino MA; Farina F; Cucchiara G
    Minerva Med; 1989 Apr; 80(4):363-6. PubMed ID: 2725937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
    Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunting in intractable ascites.
    Deans GT; Spence RA; Johnston GW
    Ulster Med J; 1985 Oct; 54(2):155-9. PubMed ID: 4095803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correction of hemodynamics after peritoneoatrial shunt in liver cirrhosis with resistant ascites].
    Vakhidov AV; Nazyrov FG; Akilov KhA; Kleĭnerman VE; Zorin AV
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):26-9. PubMed ID: 3388703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peritoneovenous shunt in ascites].
    Vasilev S; Baev S; Ivanov S
    Khirurgiia (Sofiia); 1990; 43(2):36-41. PubMed ID: 2398693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peritoneojugular shunt for irreducible ascites. Study of 16 cases].
    Quesada C; Guidicelli H; Meaulle PY; Ohanessian JH; Néron L; Harary P; de Chazelles PH; Roche J; Hostein J; Meullnet J; Treille C; Aubert H
    Med Chir Dig; 1981; 10(1):57-9. PubMed ID: 7218905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ascites in liver cirrhosis treated with peritoneovenous shunt].
    Ritland S; Stray N; Helgerud P; Bugge-Asperheim B; Bergan A; Rootwelt K
    Tidsskr Nor Laegeforen; 1984 Oct; 104(30):2104-7. PubMed ID: 6506048
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritoneo-venous shunting and endoscopic sclerotherapy in patients with portal hypertension.
    Söderlund C; Eriksson LS; Seligson U
    Ann Chir Gynaecol; 1986; 75(6):319-24. PubMed ID: 3495219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneovenous shunt in the treatment of therapy resistant ascites. Results of 7 years' experience].
    Zühlke HV; Häring R; Semsch B
    Chirurg; 1984 Apr; 55(4):253-9. PubMed ID: 6723465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvaging procedures for dysfunctional peritoneovenous shunt.
    Hu RH; Lee PH
    Hepatogastroenterology; 2001; 48(39):794-7. PubMed ID: 11462926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
    Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
    Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of the ascitic patient using LeVeen peritoneojugular shunt. Personal case reports].
    Amerio A; Giudici Cipriani A; Cananzi C; Zanelli G; Zinicola N
    Minerva Chir; 1986 Feb; 41(3-4):125-33. PubMed ID: 3515230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of intractable ascites in cirrhotic patients by portal shunt].
    Franco D
    Gastroenterol Clin Biol; 1983 May; 7(5):533-9. PubMed ID: 6873567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Denver shunt in malignant ascites].
    Van Damme H; Vaneerdeweg W; Schoofs E
    Acta Chir Belg; 1985; 85(1):43-52. PubMed ID: 2580408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.